Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Geistlich Pharma AG
Wolhusen, Central Switzerland, Switzerlandgeistlich.com ↗
- Ownership
- Private
- Employees
- ~800
- Development stage
- Other
01
Overview
Geistlich is a global market leader in regenerative dentistry with products used every 14 seconds worldwide. Their portfolio includes bone replacement material Geistlich Bio-Oss® and collagen membrane Geistlich Bio-Gide®, both developed in the 1980s[1][2].
- Therapeutic areas
- OtherNeurologyRheumatology
- Modalities
- BiomaterialsRegenerative medical devices
- Industry
- Implantable Medical Devices
02
Partnerships
Meta Technologies S.r.l.Lynch Biologics LLCBionnovation Biomedical
Beyond the preview
Go deeper on Geistlich Pharma AG.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Geistlich Pharma AG.